| scholarly article | Q13442814 |
| P50 | author | Oriana Nanni | Q43073188 |
| P2093 | author name string | D Amadori | |
| F De Paola | |||
| W Zoli | |||
| A Dubini | |||
| D Turci | |||
| A Volpi | |||
| G L Frassineti | |||
| A M Granato | |||
| E Scarpi | |||
| A Gambi | |||
| G Oliverio | |||
| P2860 | cites work | Nonparametric Estimation from Incomplete Observations | Q25938997 |
| Molecular predictors of survival after adjuvant chemotherapy for colon cancer | Q28363159 | ||
| Nuclear thymidylate synthase expression, p53 expression and 5FU response in colorectal carcinoma | Q28366577 | ||
| American Joint Committee on Cancer Prognostic Factors Consensus Conference: Colorectal Working Group | Q33875909 | ||
| Thymidylate synthase expression in stage II and III colon cancer: a retrospective review | Q34501075 | ||
| Flow cytometric analysis of ploidy in colorectal cancer: a multicentric experience. | Q35976841 | ||
| Lymphoid infiltration and prognosis in colorectal carcinoma | Q35991423 | ||
| Predictive value of vascular endothelial growth factor (VEGF) in metastasis and prognosis of human colorectal cancer | Q36115661 | ||
| Lack of correlation between thymidylate synthase levels in primary colorectal tumours and subsequent response to chemotherapy | Q36116454 | ||
| Vascular endothelial growth factor (VEGF) mRNA isoform expression pattern is correlated with liver metastasis and poor prognosis in colon cancer | Q36292182 | ||
| Prospective study of intratumoral microvessel density, p53 expression and survival in colorectal cancer | Q36617353 | ||
| Thymidilate synthase and p53 primary tumour expression as predictive factors for advanced colorectal cancer patients | Q36621223 | ||
| Association of vascular endothelial growth factor expression with tumor angiogenesis, survival and thymidine phosphorylase/platelet-derived endothelial cell growth factor expression in human colorectal cancer | Q74505899 | ||
| Increased thymidylate synthase gene expression in liver metastases from colorectal carcinoma: implications for chemotherapeutic options and survival | Q77207766 | ||
| Prognostic relevance of microvessel density in colorectal tumours | Q77896087 | ||
| Thymidylate synthase protein expression in advanced colon cancer: correlation with the site of metastasis and the clinical response to leucovorin-modulated bolus 5-fluorouracil | Q78206829 | ||
| Tumor angiogenesis as a prognostic assay for invasive ductal breast carcinoma | Q36679138 | ||
| Immunohistochemical quantitation of thymidylate synthase expression in colorectal cancer metastases predicts for clinical outcome to fluorouracil-based chemotherapy | Q38466842 | ||
| Vascular endothelial growth factor expression is reduced in liver metastasis from colorectal cancer and correlates with urokinase-type plasminogen activator | Q38471890 | ||
| Method for analysis of cellular DNA content of paraffin-embedded pathological material using flow cytometry | Q38493215 | ||
| Lymphocytic infiltration and survival in rectal cancer | Q39568763 | ||
| A new prognostic factor for colorectal carcinoma, thymidylate synthase, and its therapeutic significance | Q40872945 | ||
| Vascular endothelial growth factor expression, S-phase fraction and thymidylate synthase quantitation in node-positive colon cancer: relationships with tumor recurrence and resistance to adjuvant chemotherapy | Q43573408 | ||
| Quantitation of intratumoral thymidylate synthase expression predicts for disseminated colorectal cancer response and resistance to protracted-infusion fluorouracil and weekly leucovorin | Q43645955 | ||
| Prognostic factors in colorectal cancer. Literature review for clinical application. | Q43707850 | ||
| Thymidylate synthase levels: prognostic, predictive, or both? | Q43937138 | ||
| Thymidylate synthase expression in colorectal cancer: a prognostic and predictive marker of benefit from adjuvant fluorouracil-based chemotherapy | Q43937145 | ||
| Investigation of the prognostic and predictive value of thymidylate synthase, p53, and Ki-67 in patients with locally advanced colon cancer | Q43937149 | ||
| The role of thymidylate synthase expression in prognosis and outcome of adjuvant chemotherapy in patients with rectal cancer | Q43960974 | ||
| Tumor angiogenesis in stage II colorectal carcinoma: association with survival | Q44428188 | ||
| p53 point mutations and thymidylate synthase messenger RNA levels in disseminated colorectal cancer: an analysis of response and survival. | Q46365618 | ||
| The role of thymidylate synthase levels in the prognosis and the treatment of patients with colorectal cancer | Q50875167 | ||
| Thymidylate synthase as a predictor of response. | Q54126135 | ||
| Combined role of tumor angiogenesis,bcl-2, and p53 expression in the prognosis of patients with colorectal carcinoma | Q58212170 | ||
| Histopathological grade, mucinous differentiation and DNA ploidy in relation to prognosis in colorectal carcinoma | Q58423641 | ||
| Fixation Time and Microwave Oven Irradiation Affect Immunocytochemical p53 Detection in Formalin-Fixed Paraffin Sections | Q63302056 | ||
| DNA ploidy in colorectal cancer, heterogeneity within and between tumors and relation to survival | Q63753604 | ||
| Prognostic correlations of operable carcinoma of the rectum | Q70078900 | ||
| Vascular density and the response of breast carcinomas to mastectomy and adjuvant chemotherapy | Q70478665 | ||
| Tumor angiogenesis as a predictor of recurrence and survival in patients with node-negative colon cancer | Q70799598 | ||
| Prognostic significance of the microvascular count in colorectal cancer | Q71093025 | ||
| Angiogenesis as an unfavorable prognostic factor in human colorectal carcinoma | Q71170174 | ||
| Tumor angiogenesis in primary and metastatic colorectal cancers | Q71591080 | ||
| Angiogenesis in colorectal tumors: microvessel quantitation in adenomas and carcinomas with clinicopathological correlations | Q71804861 | ||
| From Dukes through Jass: pathological prognostic indicators in rectal cancer | Q72500139 | ||
| Thymidylate synthase gene and protein expression correlate and are associated with response to 5-fluorouracil in human colorectal and gastric tumors | Q72611029 | ||
| Thymidylate synthase inhibition after administration of fluorouracil with or without leucovorin in colon cancer patients: implications for treatment with fluorouracil | Q72729387 | ||
| Prognostic significance of DNA ploidy, S-phase fraction, and P-glycoprotein expression in colorectal cancer | Q73184474 | ||
| Vessel counts and expression of vascular endothelial growth factor as prognostic factors in node-negative colon cancer | Q73360651 | ||
| p53 gene mutation, microsatellite instability and adjuvant chemotherapy: impact on survival of 388 patients with Dukes' C colon carcinoma | Q73378925 | ||
| Histopathological grade, mucinous differentiation and DNA ploidy in relation to prognosis in colorectal carcinoma | Q73442627 | ||
| Immunohistochemically detected thymidylate synthase in colorectal cancer: an independent prognostic factor of survival | Q73483253 | ||
| Expression of vascular endothelial growth factor and thrombospondin-1 in colorectal carcinoma | Q73552922 | ||
| Tumor microvessel density and prognosis in node-negative breast cancer | Q73554861 | ||
| Prognostic role of thymidylate synthase, thymidine phosphorylase/platelet-derived endothelial cell growth factor, and proliferation markers in colorectal cancer | Q73605081 | ||
| Prognostic value of vascular endothelial growth factor expression in colorectal cancer patients | Q73670868 | ||
| Thymidylate synthase is a predictor for response and resistance in hepatic artery infusion chemotherapy | Q73731535 | ||
| Relation between thymidylate synthase expression and survival in colon carcinoma, and determination of appropriate application of 5-fluorouracil by immunohistochemical method | Q73737715 | ||
| Expression of vascular endothelial growth factor can predict event-free survival in stage II colon cancer | Q74067245 | ||
| P433 | issue | 8 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 868-875 | |
| P577 | publication date | 2002-10-01 | |
| P1433 | published in | British Journal of Cancer | Q326309 |
| P1476 | title | Role of biological markers in the clinical outcome of colon cancer | |
| P478 | volume | 87 |
| Q33266134 | Assessment of angiogenesis expression and its relationship with prognosis of colorectal cancer by conventional and computer-assisted histopathological image analysis |
| Q46160850 | Correlation between thymidylate synthase protein expression and gene polymorphism with clinicopathological parameters in colorectal carcinoma |
| Q27853168 | Decreased peritherapeutic VEGF expression could be a predictor of responsiveness to first-line FOLFIRI plus bevacizumab in mCRC patients |
| Q39539087 | Elevated preoperative carcinoembryonic antigen (CEA) and Ki67 is predictor of decreased survival in IIA stage colon cancer |
| Q37424106 | Expression of delta-like ligand 4 (Dll4) and markers of hypoxia in colon cancer |
| Q36249234 | Have we made progress in pharmacogenomics? The implementation of molecular markers in colon cancer |
| Q80955233 | Hypoxia, angiogenesis and apoptosis markers in locally advanced rectal cancer |
| Q36614453 | Microvessel density and VEGF expression are prognostic factors in colorectal cancer. Meta-analysis of the literature |
| Q27013620 | Molecular mechanisms of lymphatic metastasis in solid tumors of the gastrointestinal tract |
| Q35242758 | Multimodality imaging to predict response to systemic treatment in patients with advanced colorectal cancer. |
| Q44344925 | Predictive value of vascular endothelial growth factor overexpression in early relapse of colorectal cancer patients after curative resection. |
| Q52595509 | Prognostic Value of ACVRL1 Expression in Metastatic Colorectal Cancer Patients Receiving First-line Chemotherapy With Bevacizumab: Results From the Triplet Plus Bevacizumab (TRIBE) Study. |
| Q51964015 | The essential role of the in situ immune reaction in human colorectal cancer. |
| Q30570866 | Thymidylate synthase expression and prognosis in colorectal cancer: a meta-analysis of colorectal cancer survival data. |
| Q35862225 | Thymidylate synthase expression and prognosis of patients with gastrointestinal cancers receiving adjuvant chemotherapy: a review |
| Q24795468 | Thymidylate synthetase mRNA levels are increased in liver metastases of colorectal cancer patients resistant to fluoropyrimidine-based chemotherapy |
| Q64969774 | Vascular endothelial growth factor-A and -C: expression and correlations with lymphatic metastasis and prognosis in colorectal cancer. |
Search more.